PALI Palisade Bio, Inc.
1.480USD-0.67%Mkt Cap: 257.92M $P/E: 2.471d ago
Palisade Bio, Inc., a clinical-stage biopharmaceutical company, engages in developing oral phosphodiesterase-4 inhibitor prodrugs designed for targeted delivery to the terminal ileum and colon in the United States. Its l…
Industry Peers
Biotechnology$128.08BUSDP/E 29.4
$78.44BUSD
$76.40BUSDP/E 18.4
$57.03BUSDP/E 37.3
$58.08BUSDP/E 35.4
$42.24BUSDP/E 18.0
$43.05BUSD
$41.41BUSDP/E 65.1
$32.80BUSDP/E 30.2
$30.03BUSDP/E 37.8
$25.10BUSD
$23.93BUSD
$22.99BUSDP/E 14.5
$22.27BUSDP/E 30.7
$22.54BUSDP/E 28.9
$22.22BUSD
$15.03BUSDP/E 17.5
$15.01BUSDP/E 15.8
$14.48BUSDP/E 18.4
$14.32BUSD
Key Statistics
Company
Market Cap257.92M USD
Enterprise Value134.49M USD
Revenue (TTM)500.00K USD
Gross Profit500.00K USD
Net Income (TTM)-16.78M USD
Revenue/Share0.0030 USD
Last Price1.480 USD
Fiscal Year EndDec 2025
MR QuarterJun 2026
Employees14
CountryUS
SectorHealthcare
IndustryBiotechnology
ISIN—
Valuation
P/E (Trailing)2.47
P/E (Forward)-5.32
PEG—
EV/EBITDA-3.81
EV/Revenue268.99
P/S519.33
P/B2.13
EPS (TTM)0.60
EPS (Forward)-0.28
52W Range
0.640038% of range2.860
52W High2.860 USD
52W Low0.6400 USD
Profitability
Gross Margin100.00%
Oper. Margin-2339.60%
EBITDA Margin0.00%
Profit Margin0.00%
ROE-12.97%
ROA-12.49%
Growth
Revenue Growth—
Earnings Growth—
Cash Flow & Leverage
Operating CF-10.85M USD
CapEx (TTM)—
FCF Margin-1730.83%
FCF Yield-3.36%
Net Debt-125.17M USD
Net Debt/EBITDA3.54
Balance Sheet
Debt/Equity0.00
Current Ratio24.26
Quick Ratio23.96
Book Value/Sh0.70 USD
Cash/Share0.72 USD
Dividends
Fwd Div Rate—
Trail. Div Rate0.00 USD
Div. Yield0.00%
5Y Avg Yield—
Payout Ratio0.00%
Ex-Div Date—
Pay DateJul 18, 2019
Splits
Last Split1:15
Split DateApr 8, 2024
Analyst Consensus
Rating1.1 (Strong Buy)
Strong BuyBuyHoldSellStr. Sell
Target (Mean)10.22 USD
Upside (mean)+590.7%
Target Range5.000 USD – 25.00 USD
5.000+590.7% to mean25.00
# Analysts9
Ownership
Shares Out.174.27M
Float138.85M
Insiders2.15%
Institutions101.34%
Short Interest
Short Ratio15.9d
Short % Float17.37%
Short % Out.17.37%
Shares Short30.27M
Short (prev mo.)33.39M
Technical
SMA 501.900 (-22.1%)
SMA 2001.914 (-22.7%)
Beta1.62
S&P 52W Chg16.45%
Avg Vol (30d)2.85M
Avg Vol (10d)3.58M
Technical Indicators
RSI (14)37.7
MACD-0.1490
MACD Signal-0.1402
MACD Hist.-0.0088
BB Upper2.241 USD
BB Middle1.683 USD
BB Lower1.124 USD
BB Width66.44%
ATR (14)0.1112 USD
Vol Ratio (20d)0.23x